A detailed history of Yarra Square Partners LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Yarra Square Partners LP holds 200,000 shares of BHC stock, worth $1.56 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
200,000
Holding current value
$1.56 Million
% of portfolio
0.52%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.82B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Yarra Square Partners LP Portfolio

Follow Yarra Square Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarra Square Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Yarra Square Partners LP with notifications on news.